Header image
              
Srovnal Josef M.D., Ph.D.
Journals
        In Reply: Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence.        
                  Neurosurgery.                
                  2023,
                
                              19(3),
                  
                              e74-e75,
                          
                  ISSN: 0148-396X,
                
                
                              PMID: 36700746,                          
                 
                          
        
      
    
        Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival.        
                  Translational Lung Cancer Research.                
                  2022,
                
                              11(10),
                  
                              2040-2050,
                          
                  ISSN: 2218-6751,
                
                
                              PMID: 36386452,                          
                 
                          
        
      
    Books & book chapters
        Detekce nádorových biomarkerů v molekulárně biologické laboratoři,
        
                  1. vyd,
                
                  Olomouc,
                
                  Univerzita Palackého v Olomouci,
        
                  2012,
        
                              144 s,
                          
                              Dedication: MOLONKOL CZ.1.07/2.3.00/09.0089,
                          
                  ISBN: 978-80-244-3002-7,
                
        
      
    Open positions
| Project: | Liquid biopsies in experimental and clinical oncology | 
|---|---|
| Supervisors: | Srovnal Josef M.D., Ph.D. | 
| Available: | 2 | 
| Intended for: | Doctoral training | 
| Summary: | 2 places in full-time or combined form of study | 
| Project: | New prognostic and predictive factors in solid tumors | 
|---|---|
| Supervisors: | Srovnal Josef M.D., Ph.D. | 
| Available: | 2 | 
| Intended for: | Doctoral training | 
| Summary: | 2 places in full-time or combined form of study | 
| Project: | New prognostic and predictive factors in solid tumors | 
|---|---|
| Supervisors: | Srovnal Josef M.D., Ph.D. | 
| Available: | 2 | 
| Intended for: | Doctoral training | 
| Summary: | 2 full-time positions | 
| Project: | Identification of molecular targets and mechanisms of resistance in antitumor drugs | 
|---|---|
| Supervisors: | Srovnal Josef M.D., Ph.D., Hajdúch Marián M.D., Ph.D. | 
| Available: | 2 | 
| Intended for: | Doctoral training | 
| Summary: | 2 places in full-time study | 
| Project: | Diagnosis and treatment of rare diseases | 
|---|---|
| Supervisors: | Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D. | 
| Available: | 2 | 
| Intended for: | Doctoral training | 
| Summary: | 2 places in full-time study | 
| Project: | Liquid biopsies in experimental and clinical oncology | 
|---|---|
| Supervisors: | Srovnal Josef M.D., Ph.D. | 
| Available: | 2 | 
| Intended for: | Doctoral training | 
| Summary: | 2 full-time positions | 
| Project: | Diagnosis and treatment of rare diseases | 
|---|---|
| Supervisors: | Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D., Adam Tomáš Ph.D. | 
| Available: | 3 | 
| Intended for: | Doctoral training | 
| Summary: | 3 full-time positions |